Skip to main content
Czech Republic university's cancer drug licensed to Artios
3/7/2018

Masaryk University's nuclease drug development program for cancer treatment that targets DNA damage response was licensed to Artios Pharma. The firm also gets the option to commercialize the product.

Full Story: